A small-scale study published in Circulation March 3 has revealed a potential new culprit behind sudden cardiac death in patients with arrhythmogenic right ventricular cardiomyopathy: integrin β1D.

Blood travels differently through women’s hearts than it does through men’s, research has found, suggesting cardiologists may benefit from tailoring their treatments to a specific sex.

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

Brigham and Women’s Hospital physicians have discovered that irregular sleep patterns can significantly hike a person’s risk for heart disease, even if they’re otherwise healthy.

Drugs used to treat opioid use disorder may also be successful in improving the health outcomes of patients admitted to the hospital for injection drug use-associated endocarditis, according to research out of Boston.

Researchers at Imperial College London have developed a new type of sensor that can track vital signs in both humans and animals, suggesting the ever-growing wearables trend is expanding to include pets and livestock.

An analysis of the 2015 SPRINT trial has found that, if participants continued taking their antihypertensive medications for the remainder of their lives, intensive blood pressure control could add between six months and three years to their lifespan.

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.